Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Pfizer Tikosyn Roll-Out Tied To Hospital And Physician Training Program

Executive Summary

Pfizer is developing a pilot training program in preparation for the launch of the anti-arrhythmic Tikosyn (dofetilide) in the first quarter of 2000.

You may also be interested in...



CERTs Risk Management Agenda Includes Tikosyn Study, Workshops

The initial results from a CERT study of the risk management program for Pfizer's anti-arrhythmia drug Tikosyn (dofetilide) may indicate some practical limits to well-designed monitoring plans, Office of Postmarketing Drug Risk Assessment Director Peter Honig, MD, suggested Nov. 5

CERTs Risk Management Agenda Includes Tikosyn Study, Workshops

The initial results from a CERT study of the risk management program for Pfizer's anti-arrhythmia drug Tikosyn (dofetilide) may indicate some practical limits to well-designed monitoring plans, Office of Postmarketing Drug Risk Assessment Director Peter Honig, MD, suggested Nov. 5

FDA To Study "Labeling Fatigue": Do Serial Changes Influence Prescribing?

FDA is planning an internal research effort to examine the concept of "labeling fatigue," which suggests that serial label changes or extensive warnings in the package insert have limited ability to alter prescribing behavior.

Related Content

UsernamePublicRestriction

Register

PS034979

Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel